Literature DB >> 28729767

Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer.

Pei-Hung Chang1,2, Cheng-Hsu Wang1,2, Eric Yen-Chao Chen1, Shih-Wei Yang1, Wen-Chi Chou1, Jason Chia-Hsun Hsieh1, Feng-Che Kuan1, Kun-Yun Yeh1,2.   

Abstract

OBJECTIVE: This study aims to evaluate the impact and potential prognostic roles of the pre- and post-treatment Glasgow prognostic score (GPS) and the change thereof in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy (CCRT).
METHODS: We collected GPS and clinicopathological data of 139 stage III, IVA, and IVB head and neck cancer patients who underwent CCRT between 2008 and 2011. Their GPSs pre- and post-CCRT and the change thereof were analyzed for correlations with recurrence and survival.
RESULTS: The GPS changed in 72 (51.8%) patients, with worse scores observed post-CCRT in 65 (90.3%) of the GPS changed patients. Patients in the improved GPS group showed a tendency toward better survival. From the multivariate analysis, the post-CCRT GPS level was an independent prognostic factor in addition to tumor stage.
CONCLUSIONS: After CCRT, a high GPS was revealed to be an important predictor of survival for advanced head and neck cancer.

Entities:  

Keywords:  Glasgow prognostic score (GPS); cachexia; chemoradiation; head and neck cancer; inflammation; nutrition

Year:  2017        PMID: 28729767      PMCID: PMC5497203          DOI: 10.21147/j.issn.1000-9604.2017.03.02

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  23 in total

1.  Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer.

Authors:  Masahiro Nakayama; Keiji Tabuchi; Akira Hara
Journal:  Head Neck       Date:  2014-09-25       Impact factor: 3.147

Review 2.  The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.

Authors:  Donald C McMillan
Journal:  Cancer Treat Rev       Date:  2012-09-17       Impact factor: 12.111

3.  Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy.

Authors:  Paula Ravasco; Isabel Monteiro-Grillo; Pedro Marques Vidal; Maria Ermelinda Camilo
Journal:  Head Neck       Date:  2005-08       Impact factor: 3.147

4.  The impact of nutritional status on the prognoses of patients with advanced head and neck cancer.

Authors:  P A van Leeuwen; D J Kuik; W M Klop; H P Sauerwein; G B Snow; J J Quak
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

5.  Use of recombinant human soluble TNF receptor in anorectic tumor-bearing rats.

Authors:  G F Torelli; M M Meguid; L L Moldawer; C K Edwards; H J Kim; J L Carter; A Laviano; F Rossi Fanelli
Journal:  Am J Physiol       Date:  1999-09

6.  Low body mass index at 3 months following adjuvant chemoradiation affects survival of postoperative locally advanced oral cavity cancer patients.

Authors:  Pei-Hung Chang; Cheng-Hsu Wang; Jen-Seng Huang; Chien-Hong Lai; Tsung-Han Wu; Yii-Jeng Lan; Jason Chien-Sheng Tsai; Eric Yen-Chao Chen; Shih-Wei Yang; Kun-Yun Yeh
Journal:  Laryngoscope       Date:  2012-08-09       Impact factor: 3.325

7.  Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells.

Authors:  C R Plata-Salamán; S E Ilyin; D Gayle
Journal:  Am J Physiol       Date:  1998-08

8.  Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer.

Authors:  Matthew R Dixon; Jason S Haukoos; Sejal M Udani; Jesse J Naghi; Tracey D Arnell; Ravin R Kumar; Michael J Stamos
Journal:  Arch Surg       Date:  2003-09

9.  Cancer cachexia: developing multimodal therapy for a multidimensional problem.

Authors:  K C H Fearon
Journal:  Eur J Cancer       Date:  2008-03-28       Impact factor: 9.162

10.  Omega-3 fatty acid-, micronutrient-, and probiotic-enriched nutrition helps body weight stabilization in head and neck cancer cachexia.

Authors:  Kun-Yun Yeh; Hung-Ming Wang; John W-C Chang; Jen-Seng Huang; Chien-Hong Lai; Yii-Jenq Lan; Tsung-Han Wu; Pei-Hung Chang; Hang Wang; Chang-Jer Wu; Simon Hsia; Cheng-Hsu Wang
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-04-02
View more
  4 in total

1.  A cumulative score based on preoperative fibrinogen and the neutrophil-lymphocyte ratio to predict outcomes in resectable gastric cancer.

Authors:  Xuechao Liu; Zhimin Liu; Enzi Lin; Yingbo Chen; Xiaowei Sun; Zhiwei Zhou
Journal:  Cancer Manag Res       Date:  2018-08-28       Impact factor: 3.989

2.  Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer.

Authors:  Kristin Stokke; Marie Søfteland Sandvei; Bjørn Henning Grønberg; Marit Slaaen; Kristin T Killingberg; Tarje O Halvorsen
Journal:  Clin Med Insights Oncol       Date:  2022-03-22

3.  Pretreatment Glasgow Prognostic Score Correlated with Serum Histidine Level and Three-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma and Optimal Performance Status.

Authors:  Kun-Yun Yeh; Chao-Hung Wang; Hang Huong Ling; Chia-Lin Peng; Zih-Syuan Chen; Simon Hsia
Journal:  Nutrients       Date:  2022-08-24       Impact factor: 6.706

4.  Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma.

Authors:  Chen Zheng; Shuaibin Liu; Jiexiong Feng; Xiang Zhao
Journal:  Cancer Manag Res       Date:  2020-04-01       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.